Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Sodium Glucose Cotransporter 2 Inhibitors for Prevention of Postoperative Acute Kidney Injury in Cardiac Surgery Patients - a Randomized, Placebo-controlled, Multi-centre, Phase IV Clinical Trial

NCT05590143 is registered in ClinicalTrials.gov with Amsterdam UMC as lead sponsor.

NCT NCT05590143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05590143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Sodium Glucose Cotransporter 2 Inhibitors for Prevention of Postoperative Acute Kidney Injury in Cardiac Surgery Patients - a Randomized, Placebo-controlled, Multi-centre, Phase IV Clinical Trial
Lead sponsor
Amsterdam UMC
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 9, 2023
Completion date
September 30, 2025
Enrollment
784 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cardiac surgery, sodium-glucose transporter 2 inhibitor